Zhao, Zewei
Wang, Huijuan
Kang, Ning
Wang, Zhongyu
Hou, Xiukun
Hu, Linfei
Qie, Shuo
Guo, Jianping
Wei, Songfeng
Ruan, Xianhui
Zheng, Xiangqian
Article History
Received: 31 August 2022
Accepted: 23 November 2022
First Online: 5 December 2022
Declarations
:
: All patients received written informed consent. The animal study was approved by the ethics committee of the tumor hospital of Tianjin Medical University (No. 2022001).
: All authors have read and approved of its submission to this journal.
: The authors declare no competing interests.